Decrease of elastic moduli of DOPC bilayers induced by a macrolide antibiotic, azithromycin

N Fa1, L Lins, P J Courtoy

  • 1Université Catholique de Louvain, Unité de Pharmacologie Cellulaire et Moléculaire, Avenue E. Mounier 73, Bt 7370, B-1200 Brussels, Belgium.

Insights

The antibiotic azithromycin alters the elastic properties of lipid bilayers, decreasing their cohesion. This drug-induced change in membrane elasticity influences membrane deformation and drug-membrane interactions, impacting cellular pharmacology.

Area of Science:

  • Biophysics
  • Membrane Biophysics
  • Pharmacology

Background:

  • Elastic properties of membrane bilayers are crucial for their function and can be modulated by pharmacological agents.
  • Previous studies indicated azithromycin erodes DPPC domains in DOPC lipid matrices.
  • The effect of azithromycin on DOPC cohesion and membrane elasticity remained uninvestigated.

Purpose of the Study:

  • To investigate the effect of azithromycin on the elastic properties of dioleoylphosphatidylcholine (DOPC) giant unilamellar vesicles (GUVs).
  • To determine how azithromycin influences membrane fluctuations and lipid bilayer cohesion.
  • To provide biophysical evidence for azithromycin's interaction with lipid membranes.

Main Methods:

  • Microcinematographic and morphometric analyses of GUVs.
  • Micropipette aspiration technique to quantify elastic moduli.
  • Computer modeling of azithromycin-DOPC bilayer interactions.

Main Results:

  • Azithromycin addition enhanced lipid membrane fluctuations and disrupted larger GUVs.
  • Azithromycin significantly decreased the bending modulus (k(c)) and apparent area compressibility modulus (K(app)) of DOPC bilayers.
  • Computer modeling predicted azithromycin insertion at the bilayer interface, reducing inter-molecule interactions and increasing molecular surface area.

Conclusions:

  • Azithromycin inserts into the DOPC lipid bilayer, reducing its cohesion and elastic moduli.
  • This alteration in membrane elasticity facilitates the merging of DPPC into the DOPC matrix, consistent with prior observations.
  • These findings provide the first biophysical evidence of an amphiphilic antibiotic altering lipid elastic moduli, with implications for drug-lipid interactions and cellular pharmacology.

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...